You are viewing: China Sleep Apnea Devices Market analysis
Part of: Sleep Apnea Devices Market (Global)

The China Sleep Apnea Devices Market was valued at $264.8 Million in 2025 and projected to reach to $480.8 Million by 2030, representing a compound annual growth rate of 8.9%. China's sleep apnea devices market is positioned for sustained growth through 2030, driven by demographic shifts, rising healthcare spending, and improved disease awareness.

China Sleep Apnea Devices Market Trends and Insights

  • This growth trajectory reflects China's rising prevalence of obstructive sleep apnea, driven by urbanization, lifestyle changes, and increasing awareness of sleep disorders among the Chinese population.
  • China's healthcare infrastructure modernization and government initiatives to improve diagnostic capabilities are accelerating adoption of continuous positive airway pressure (CPAP) devices and alternative therapies across urban and emerging markets. The 8.9% compound annual growth rate in China significantly outpaces global trends, positioning the country as a high-growth market within the Asia Pacific region.
  • China's large patient base, combined with improving reimbursement policies and rising disposable incomes, is fueling demand for both diagnostic and therapeutic sleep apnea devices.
  • Between 2025 and 2030, China is expected to capture increasing market share as manufacturers expand distribution networks and localize product offerings to meet the specific needs of Chinese healthcare providers and patients..

Key Market Statistics

  • CAGR (2025-2030) 8.9% CAGR
  • Market Size, 2025 ~USD 264.8 Million
  • Forecast, 2030 ~USD 480.8 Million
  • Country China

China Sleep Apnea Devices Market Overview

Market Valuation Growth :

China's sleep apnea devices market is valued at USD 264.8 million in 2025, with a projected CAGR of 8.9% through 2030, reaching USD 480.8 million. This outpaces the global CAGR of 7.6%, indicating China's accelerating market momentum.

Urbanization & Lifestyle Drivers :

Rapid urbanization and changing lifestyle patterns in China have significantly increased obstructive sleep apnea prevalence. Sedentary work habits, increased stress, and dietary changes contribute to rising OSA cases across urban populations.

Healthcare Infrastructure Modernization :

China's ongoing healthcare system upgrades and increased investment in diagnostic capabilities are expanding access to sleep apnea screening and treatment. Government initiatives support improved detection and management of sleep disorders nationwide.

Growing Awareness & Diagnosis :

Increasing public awareness of sleep disorders and their health impacts is driving patient diagnosis rates in China. Enhanced medical education and digital health platforms are improving recognition of sleep apnea symptoms among both healthcare providers and consumers.

China Sleep Apnea Devices Market Dynamics

  • The country's large population base combined with increasing prevalence of OSA creates substantial market opportunities for device manufacturers and healthcare providers.
  • Government healthcare reforms and expanding insurance coverage are expected to accelerate device adoption across urban and emerging markets. The competitive landscape in China will intensify as both domestic manufacturers and international players expand their presence.
  • Innovation in portable diagnostic devices, CPAP technology, and digital health integration will be critical differentiators.
  • Strategic partnerships with Chinese healthcare institutions and distribution networks will be essential for capturing market share in this high-growth region..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Stryker Corporation
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • JOHNSON & JOHNSON

    Key Takeaways

    • China's sleep apnea devices market will grow from USD 264.8 million (2025) to USD 480.8 million (2030) at an 8.9% CAGR, outpacing global growth rates.
    • Rising urbanization and lifestyle changes in China are driving increased prevalence of obstructive sleep apnea and demand for diagnostic and therapeutic devices.
    • China's improving healthcare infrastructure and government-backed reimbursement initiatives are accelerating device adoption across both urban centers and emerging regions.
    • Manufacturers are expanding localized product portfolios and distribution networks in China to capitalize on the country's large patient population and growing middle class.

    Sleep Apnea Devices Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment ORAL APPLIANCES (Type)
    Forecast Period 2025–2030
    Growth Rate CAGR of 7.6% from 2025 to 2030
    Largest Segment THERAPEUTIC DEVICES (Product)
    Market Size Base Year (Billions) ~USD 6.95 (2025)
    Revenue Forecast (Billions) ~USD 10.03 (2030)
    Segments Covered Product, Type

    China Sleep Apnea Devices Market Report Segmentation

    2 segment dimensions are covered across the global market.

    By Product

    • Diagnostic Devices
    • Therapeutic Devices

    By Type

    • Accessories
    • Actigraphy Systems
    • Ambulatory Psg Devices
    • Apap Devices
    • Bpap Devices
    • Chin Restraints
    • Clinical Psg Devices
    • Communication Accessories
    • Cpap Devices
    • Cushions
    • Daytime-Nighttime Appliances
    • Facial Interfaces
    • Full-Face Masks
    • Home Sleep Testing Devices
    • Humidifier Accessories
    • Mandibular Advancement Devices
    • Masks
    • Nasal Masks
    • Nasal Pillow Masks
    • Oral Appliances
    • Other Accessories
    • Other Therapeutic Devices
    • Oximeters
    • Pap Devices
    • Power Accessories
    • Psg Devices
    • Sleep Screening Devices
    • Tongue-Retaining Devices
    • Transportation Accessories

    Target Audience

    • Medical Device Manufacturers : Sleep apnea device manufacturers need China-specific market data to assess expansion opportunities, competitive positioning, and revenue potential in this high-growth market outpacing global averages.
    • Healthcare Investors & PE Firms : Investment professionals require detailed China market analysis to evaluate portfolio opportunities, assess risk-adjusted returns, and identify acquisition targets in the sleep apnea devices sector.
    • Hospital & Clinic Operators : Healthcare facility administrators need market insights to plan sleep disorder diagnostic and treatment programs, procurement strategies, and capital allocation for sleep apnea device investments.
    • Distributors & Importers : Medical device distributors and importers require China market intelligence to evaluate product demand, pricing strategies, supplier relationships, and distribution channel optimization.
    • Government & Policy Makers : Healthcare policy officials and government agencies need market data to inform healthcare reform initiatives, reimbursement policies, and strategic planning for sleep disorder management programs.

    Key Companies in the China Sleep Apnea Devices Market

    CompanyHQOwnershipStrongest segments
    HENRY SCHEINUnited StatesPublic CompanyTherapeutic – Oral Appliances,Therapeutic – PAP Devices (CPAP, APAP, BPAP),Therapeutic – Masks and Consumables,
    ROSSMAX INTERNATIONAL LTDTaiwanPublic CompanyTherapeutic – PAP (CPAP, APAP, BPAP),Therapeutic – Oral Appliances,Therapeutic – Masks,
    SANOFISpainPublic CompanyTherapeutic – PAP (CPAP, APAP, BPAP),Therapeutic – Oral Appliances,Therapeutic – Masks,
    DANAHER CORPORATIONUnited StatesPublic CompanyTherapeutic – PAP (CPAP, APAP, BPAP),Therapeutic – Oral Appliances,Therapeutic – Masks,
    RESMEDUnited StatesPublic CompanyTherapeutic – PAP devices (CPAP, APAP, BPAP),Therapeutic – Masks and interfaces,Therapeutic – Oral appliances,
    KONINKLIJKE PHILIPS N.V.NetherlandsPublic CompanyTherapeutic – PAP (CPAP, APAP, BPAP),Therapeutic – Masks and Interfaces,Therapeutic – Oral Appliances,
    FISHER & PAYKEL HEALTHCARE LIMITEDNew ZealandPublic CompanyTherapeutic – PAP devices (CPAP, APAP, BPAP),Therapeutic – Masks and interfaces,Therapeutic – Oral appliances,
    INSPIRE MEDICAL SYSTEMS, INC.United StatesPublic CompanyTherapeutic – Neurostimulation System (competes with PAP/Oral Appliances/Masks),Diagnostic-Linked Services (competes with PSG/Home Sleep Testing/Oximeter adjacencies),
    SOMNOMEDAustraliaPublic CompanyTherapeutic – Oral Appliances (SomnoDent portfolio, SomMorning Repositioner, SomnoBrux),Adjacencies – Cleaning and maintenance (SomTabs) and related accessories,Non-OSA dental protection (SomnoBrux-only use cases),
    COMPUMEDICS LIMITEDAustraliaPublic CompanyDiagnostic – PSG Systems (lab-based and ambulatory),Diagnostic – Home Sleep Testing & Wearables,Diagnostic – Oximetry and Ancillary Monitoring,
    BMCUnited StatesPrivate CompanyTherapeutic Devices (PAP, Oral Appliances, Masks),Diagnostic Devices (PSG, Home Sleep Testing, Oximeter),Healthcare IT / Workflow Enablement for Sleep Care,
    PROSOMNUS SLEEP TECHNOLOGIESUnited StatesPrivate CompanyTherapeutic – Oral Appliances,Therapeutic – PAP (CPAP, APAP, BPAP),Therapeutic – Masks,

    HENRY SCHEIN

    Henry Schein is a publicly traded United States company founded in 1932 with 25,000 employees.

    ROSSMAX INTERNATIONAL LTD

    Rossmax International Ltd is a publicly traded company based in Taiwan, founded in 1988.

    SANOFI

    Sanofi is a publicly traded pharmaceutical company based in Spain, founded in 1994 with 74,846 employees.

    DANAHER CORPORATION

    Danaher Corporation is a publicly traded United States company founded in 1969 with 59,000 employees.

    RESMED

    ResMed is a publicly traded United States company founded in 1989 with 10,600 employees.

    KONINKLIJKE PHILIPS N.V.

    Koninklijke Philips N.V. is a publicly traded Dutch company founded in 1891 with 64,317 employees.

    FISHER & PAYKEL HEALTHCARE LIMITED

    Fisher & Paykel Healthcare Limited is a publicly traded New Zealand company founded in 1934 with 7,396 employees.

    INSPIRE MEDICAL SYSTEMS, INC.

    Inspire Medical Systems, Inc. is a publicly traded United States company founded in 2007 with 1,333 employees.

    SOMNOMED

    SomnoMed is a publicly traded Australian company founded in 1987 with 300 employees.

    COMPUMEDICS LIMITED

    Compumedics Limited is a publicly traded Australian company founded in 1987 with 175 employees.

    BMC

    BMC is a United States-based private company founded in 1980 with 6,700 employees.

    PROSOMNUS SLEEP TECHNOLOGIES

    ProSomnus Sleep Technologies is a United States-based private company founded in 2016 with 136 employees.

    Reasons to Buy this Report

    • Market Size & Growth Validation : Obtain precise market valuation data for China (USD 264.8M in 2025) with verified CAGR of 8.9% through 2030. Validate investment decisions and revenue projections with authoritative market intelligence specific to the Chinese market.
    • Competitive Positioning Strategy : Understand China's unique market dynamics, including local competitor landscape, distribution channels, and regulatory requirements. Develop targeted go-to-market strategies that account for China's healthcare infrastructure and consumer preferences.
    • Growth Driver Identification : Analyze specific factors driving China's market expansion: urbanization trends, lifestyle changes, healthcare modernization, and awareness initiatives. Identify which segments and regions within China offer the highest growth potential for your business.
    • Investment & Partnership Opportunities : Identify strategic partnership opportunities with Chinese healthcare providers, distributors, and manufacturers. Evaluate market entry strategies and assess the viability of acquisitions or joint ventures in this high-growth market.
    • Regulatory & Reimbursement Insights : Gain clarity on China's evolving regulatory landscape, insurance coverage expansion, and government healthcare initiatives affecting device adoption. Understand pricing strategies and reimbursement pathways critical for market success.

    Frequently asked questions

    What is the current market size of sleep apnea devices in China?

    China's sleep apnea devices market was valued at USD 264.8 million in 2025 and is projected to grow to USD 480.8 million by 2030.

    What is the expected growth rate for sleep apnea devices in China?

    China's sleep apnea devices market is expected to grow at a compound annual growth rate (CAGR) of 8.9% from 2025 to 2030.

    What factors are driving growth in China's sleep apnea devices market?

    Key drivers include rising urbanization, lifestyle changes increasing sleep apnea prevalence, improved healthcare infrastructure, government reimbursement initiatives, and growing awareness of sleep disorders among Chinese patients.

    How does China's market growth compare to global trends?

    China's 8.9% CAGR significantly exceeds the global sleep apnea devices market CAGR of 7.6%, making China one of the fastest-growing markets in the Asia Pacific region.

    What types of sleep apnea devices are most in demand in China?

    Continuous positive airway pressure (CPAP) devices and alternative therapeutic devices are experiencing strong demand in China, supported by improved diagnostic capabilities and healthcare provider adoption.

    RESEARCH METHODOLOGY

    The study analyzes key market dynamics, such as drivers, opportunities, restraints, challenges, and key player strategies. To track company developments such as acquisitions, product launches and approvals, expansions, agreements, and partnerships of the leading players, the competitive landscape of the sleep apnea devices market is analyzed to evaluate market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were used to estimate the market size. The market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

    The four steps involved in estimating the market size are

    Secondary Research

    In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

    Primary Research

    In the primary research process, various supply and demand sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess prospects.

    The following is a breakdown of the primary respondents:

    Sleep Apnea Devices Market

    Note 1: Others include sales, marketing, and product managers.

    Note 2: Companies are classified into tiers based on their total revenues. As of 2022/2023, Tier 1 = >USD 1 million, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    COMPANY NAME DESIGNATION
    SOMNOmedcis AG (Germany) Country Manager
    ResMed (US) Regional Sales Manager

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of sleep apnea devices in the market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    • The key players in the industry have been identified through extensive secondary research
    • Primary and secondary research has determined the revenues generated by leading players operating in the sleep apnea devices market.
    • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

    Global Sleep Apnea Devices Market Size: Bottom-up and Top-down Approach

    Sleep Apnea Devices Market

    Data Triangulation

    After arriving at the overall market size by applying the abovementioned process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

    Market Definition

    Sleep apnea is a prevalent sleep disorder that is frequently undiagnosed, yet it poses significant health risks. This condition is characterized by intermittent cessation of breathing, which can last from several seconds to minutes, or by irregular breathing patterns. The most predominant form is obstructive sleep apnea (OSA), where anatomical or physiological obstructions impede airflow during sleep. Continuous positive airway pressure (CPAP) devices are commonly used to deliver air at elevated pressure through the nasal passages, effectively counteracting upper airway obstructions and facilitating normal respiration. These interventions are crucial for mitigating the associated morbidities linked with untreated sleep apnea.

    Stakeholders

    • Senior Management
    • Sleep Laboratories, Clinics, & Hospitals
    • Home Care Settings
    • Academic & research institutes
    • Finance/Procurement Department
    • R&D Department

    Report Objectives

    • To define, describe, segment, and forecast the global sleep apnea devices market by product, age group, gender, end user, and region
    • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, challenges, and trends)
    • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall sleep apnea devices market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the market segments with respect to five regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa.
    • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
    • To benchmark players within the market using the proprietary Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business and product excellence

    Get the Full Sleep Apnea Devices Market Report

    Full forecast, segment splits, and company analysis for all Sleep Apnea Devices Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status